SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NIO, Inc. is a holding company which engages in the design, manufacture, and sale of electric vehicles. Its products include the EP9 supercar and ES8 7-seater SUV. It provides users with home charging, power express valet services, and other power solutions including access to public charging, access to power mobile charging trucks, and battery swapping. It also offers other value-added services such as service package, battery payment arrangement, and vehicle financing and license plate registration. The company was founded by Bin Li and Li Hong Qin on November 28, 2014 and is headquartered in Jiading, China.

NIO Inc - ADR

NIO Inc

NIO is dominating conversations following reports of record-breaking vehicle deliveries for December and the fourth quarter, fueling strong community speculation about the company achieving its first profitable quarter. The electric vehicle maker's performance, alongside extended government subsidies for new energy vehicles in China, is generating bullish sentiment regarding its growth trajectory and competitive position against rivals. Despite some investor concern about market volatility, many remain focused on NIO's operational advancements.

Intelligent Bio Solutions, Inc. is a medical technology company, which engages in delivering testing solutions. It operates through the Intelligent Fingerprinting Products (IFPG) and Saliva Glucose Biosensor Platform (SGBP) segments. It offers biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was founded on December 5, 2016 and is headquartered in New York, NY.

Intelligent Bio Solutions Inc

One Stop Systems, Inc. engages in the design, manufacture, and marketing of computing modules and systems targeting edge deployments. It deals with the design and manufacture of high-performance customized computer and flash arrays, in-flight entertainment, and connectivity and value-added reseller with minimal customization. It operates through the OSS and OSS Europe segments. The company was founded by Stephen D. Cooper and Mark Gunn in 1998 and is headquartered in Escondido, CA.

One Stop Systems Inc

One Stop Systems (OSS) is trending due to the definitive sale of its Bressner Technology subsidiary for $22.4 million, a strategic move by management to focus on its higher-growth Edge AI compute business and strengthen its balance sheet. The community is actively discussing this, alongside strong anticipation for an imminent multi-hundred-million dollar US Army situational awareness contract, seeing OSS as significantly undervalued within the defense and AI sectors.

Xeris Biopharma Holdings, Inc. is a biopharmaceutical company, which engages in developing and commercializing products across a range of therapies. The company has three commercial products: Gvoke, Keveyis, and Recorlev. Gvoke is ready-to-use liquid glucagon for the treatment of severe hypoglycemia. Keveyis is the therapy approved in the United States to treat hyperkalemic, hypokalemic, and related variants of primary periodic paralysis (PPP). Recorlev is a cortisol synthesis inhibitor approved for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome. Its product also includes Ogluo which is used for the treatment of severe hypoglycemia in adults, adolescents, and children aged 2 years and over with diabetes mellitus. The company was founded by Steven Prestrelski in 2005 and is headquartered in Chicago, IL.

Xeris Biopharma Holdings Inc

Xeris Biopharma is actively trending after a competitor's Cushing's syndrome treatment received a regulatory decline, clearing a significant market hurdle for Xeris's approved drug, Recorlev. The community is buzzing about this as a massive tailwind, expecting substantial market share gains that bolster XERS's already strong financial performance and promising pipeline. Analysts are reflecting this positive outlook, highlighting the company's compelling growth trajectory.

ASP Isotopes, Inc. is a pre-commercial stage advanced materials company, which engages in the development of technology and processes that will allow for the enrichment of natural isotopes into higher concentration products. Its products include medical, green energy, and Industrial isotopes. The company was founded by Paul E. Mann and Robert Ainscow on September 13, 2021 and is headquartered in Washington, DC.

ASP Isotopes Inc

ASP Isotopes is currently trending following key regulatory approvals for its Renergen acquisition and new "Overweight" analyst coverage with a bullish price target. Despite these positive developments, community discussion reflects significant frustration over perceived management missteps, repeated commercial shipment delays, and ongoing dilution concerns. This creates a polarized sentiment, balancing long-term potential in critical isotope markets against short-term execution challenges.

The Goldman Sachs Group, Inc. engages in the provision of financial services. It operates through the following business segments: Global Banking and Markets, Asset and Wealth Management, and Platform Solutions. The Global Banking and Markets segment includes investment banking, global investments, and equity and debt investments. The Asset and Wealth Management segment relates to the direct-to-consumer banking business which includes lending, deposit-taking, and investing. The Platform Solutions segment includes consumer platforms such as partnerships offering credit cards and point-of-sale financing, and transaction banking. The company was founded by Marcus Goldman in 1869 and is headquartered in New York, NY.

Goldman Sachs Group, Inc.

Goldman Sachs is drawing significant attention following robust Q3 earnings and strategic moves to bolster its ETF business through acquisitions, alongside its prominent role in a rebounding M&A market. The community is actively discussing the stock's impressive run and strategic AI integration efforts, with many anticipating continued strength, while others debate its high valuation and the potential for a stock split.

Ripple is the catchall name for the cryptocurrency platform, the transactional protocol for which is actually XRP, in the same fashion as Ethereum is the name for the platform that facilitates trades in Ether. Like other cryptocurrencies, Ripple is built atop the idea of a distributed ledger network which requires various parties to participate in validating transactions, rather than any singular centralized authority. That facilitates transactions all over the world, and transfer fees are far cheaper than the likes of bitcoin. Unlike other cryptocurrencies, XRP transfers are effectively immediate, requiring no typical confirmation time.  Ripple was originally founded by a single company, Ripple Labs, and continues to be backed by it, rather than the larger network of developers that continue bitcoin’s development. It also doesn’t have a fluctuating amount of its currency in existence. Where bitcoin has a continually growing pool with an eventual maximum, and Ethereum theoretically has no limit, Ripple was created with all of its 100 billion XRP tokens right out of the gate. That number is maintained with no mining and most of the tokens are owned and held by Ripple Labs itself — around 60 billion at the latest count.  Even at the recently reduced value of around half a dollar per XRP, that means Ripple Labs is currently sitting on around $20 billion worth of the cryptocurrency (note: Ripple’s price crashed hard recently, and may be worth far less than $60 billion by time you read this). It holds 55 billion XRP in an escrow account, which allows it to sell up to a billion per month if it so chooses in order to fund new projects and acquisitions. Selling such an amount would likely have a drastic effect on the cryptocurrency’s value, and isn’t something Ripple Labs plans to do anytime soon.  In actuality, Ripple Labs is looking to leverage the technology behind XRP to allow for faster banking transactions around the world. While Bitcoin and other cryptocurrencies are built on the idea of separating financial transactions from the financial organizations of traditional currencies, Ripple is almost the opposite in every sense.  XRP by Ripple price can be found on this page alongside the market capitalization and additional stats.

Ripple

XRP is trending due to widespread community discussion surrounding a prominent influencer's bold, yet unfulfilled, prediction of a significant price surge by year-end. While many are mocking the failed forecast, others remain optimistic for 2026, citing potential catalysts like the anticipated Clarity Act, institutional ETF inflows, and upcoming token unlocks as key drivers for its future trajectory.

Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. Its products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF. The company was founded in 2013 and is headquartered in San Diego, CA.

Arcturus Therapeutics Holdings Inc

Arcturus Therapeutics is trending following mixed interim Phase 2 results for its ARCT-032 cystic fibrosis therapy, which showed signs of mucus plug reduction but limited lung function improvement, leading to significant stock volatility. Community sentiment is divided, with many viewing the sharp decline as an overreaction and highlighting the therapy's biological activity, the strength of their mRNA platform, other pipeline assets, and a high-stakes trade secret lawsuit against AbbVie as key discussion points for future value. Simultaneously, discussions around their influenza vaccine candidates are gaining traction amidst concerns over emerging flu variants.

Tidal Trust II - Defiance Daily Target 2x Long SMCI ETF

Defiance Daily Target 2X Long SMCI ETF

SMCX is trending as its community grapples with the impact of a recent dividend distribution, leading to widespread confusion and frustration over its sharp decline. Many investors are questioning why the 2x leveraged ETF is not tracking its underlying asset, SMCI, as expected, fueling concerns about decay and the potential for a reverse split. While some traders see the current suppressed levels as a buying opportunity, others warn of the significant volatility and risks inherent in such leveraged products.

Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Redwood City, CA.

Corcept Therapeutics Inc

Corcept Therapeutics is trending after its relacorilant drug for Cushing's syndrome received a Complete Response Letter from the FDA, requesting additional efficacy evidence despite a successful pivotal trial, causing a sharp stock decline. Many investors view this over 50% drop as an overreaction, highlighting the company's established, revenue-generating drug Korlym and its broader pipeline. Amidst year-end tax-loss selling and wider biotech sector volatility, community discussion centers on the potential for regulatory resolution versus further valuation adjustments.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Is TMC The Metals Co Inc Gaining or Losing Market Support?

TMC the metals (NASDAQ:TMC) Trading Down 4.8% - Time to Sell?

TMC the metals (NASDAQ:TMC) Stock Price Down 4.8% - Time to Sell...

<ul class="summary-bullets"><li>China’s export controls heightened supply risks, pushing rare earths and critical metals into strategic focus.</li><li>U.S. policy support, partnerships, and funding accelerated momentum across the sector.</li><li>Valuations diverged after the rally, with analysts still seeing selective upside despite execution risks.</li></ul>China’s hard line against President Donald Trump’s tariffs proved a blessing in disguise for at least one industry. Rare earth elements (REE) manufacturers and those making other critical metals shot to prominence amid the&nbsp;bilateral bickerings that threatened to derail the supply chain.&nbsp;China accounted for roughly 70% of global rare earth production and more than 85% of processing capacity in 2024, JPMorgan said in a report. As trade tensions between the U.S. and China escalated, Beijing&nbsp;tightened controls on the export of critical metals, stoking fears of supply shortages. These metals are essential for manufacturing high-performance permanent magnets, key components in electric motors, wind turbines, and a wide range of electronic devices.Against this backdrop, the Trump administration shifted its focus to strengthening domestic supply chains for REEs—a group of 17 metals that includes scandium, yttrium, and the 15 lanthanides—to ensure long-term supply security. Highlighting their strategic importance, JPMorgan, citing Oxford Economics, warned that even a partial disruption in REE supplies could shave around one percentage point off U.S. economic growth over two years.<h2 class="st-heading-2">Critical Metal Stocks Take Spotlight</h2>The&nbsp;<a href="https://stocktwits.com/symbol/REMX">VanEck Rare Earth and Strategic Metals ETF (REMX)</a>, which had been in a secular downtrend since early 2022, regained momentum amid rising geopolitical tensions over rare earth elements. The ETF bottomed in early April before staging a strong rally.<img src="https://news.stocktwits-cdn.com/REMX_5_YEAR_c_HART_png_c5249a3d5b.webp" alt="REMX 5-YEAR cHART.png">Source: KoyfinThe ETF has generated an 83% return this year, notably outperforming the&nbsp;<a href="https://stocktwits.com/symbol/SPY">SPDR S&amp;P 500 ETF (SPY)</a> (+16%) and the&nbsp;<a href="https://stocktwits.com/symbol/DIA">SPDR Dow Jones Industrial Average ETF Trust (DIA)</a> (+14.4%).&nbsp;<img src="https://news.stocktwits-cdn.com/REMX_vs_SPY_vs_DIA_png_1354bd76dc.webp" alt="REMX vs SPY vs DIA.png">Source: koyfinThe industry's strong performance reflects the government’s focus. The U.S., which is heavily reliant on China for its REEs, has begun to look elsewhere. It has invested $400 million in MP Materials (MP), the only company to have a REE processing facility in the U.S. The Trump administration has also negotiated partnerships with countries such as Australia and Malaysia. While China dominated production, untapped reserves are found globally.<h4 class="st-heading-4" style="text-align:center;">Global Rare Earth Production &amp; Supply&nbsp;</h4><img src="https://news.stocktwits-cdn.com/Screenshot_2025_12_19_at_5_12_17_AM_png_50c1095f36.webp" alt="Screenshot 2025-12-19 at 5.12.17 AM.png">Source: JPMorgan<h2 class="st-heading-2">Top-Performing Critical Metal Stocks</h2>Riding on the wave, some of the rare earth miners have notched up mindboggling gains this year. The&nbsp;<a href="https://stocktwits.com/symbol/TMC">Metals Company’s (TMC) stock</a> has jumped over 475% this year.&nbsp; TMC is not a rare earth miner, but is nevertheless engaged in the mining of other critical metals. Canada-based TMC is a deep-sea mining exploration company that mines polymetallic nodules, comprising nickel, cobalt, copper, and manganese in the Pacific.In June, Korea Zinc announced a strategic equity investment of $85.2 million in TMC, in exchange for 19.6 million common shares.<a href="https://stocktwits.com/symbol/TMQ">Trilogy Metals (TMQ)</a> follows with a 290% year-to-date gain. Among&nbsp;other standout REE miners are&nbsp;<a href="https://stocktwits.com/symbol/NB">NioCorp Developments</a> (NB) and&nbsp;<a href="https://stocktwits.com/symbol/MP">MP Materials (MP)</a>.<img src="https://news.stocktwits-cdn.com/Critical_mining_stocks_png_3093e33cd7.webp" alt="Critical mining stocks.png">Source: KoyfinMP Materials’ stock received a bullish upgrade from Morgan Stanley earlier this month. Analyst Carlos De Alba also increased the price target for the stock to $71 from $69.50. The analyst attributed the action to permanent magnets, and REEs such as Dysprosium and Terbium remained restricted by China.<blockquote>“We think MP is well positioned to benefit as the US looks to develop a robust ex-China supply chain with MP at the center.”</blockquote>Morgan Stanley’s bullish stance stems from MP Materials’ partnership with the Department of Defense, which materially de-risks the company’s business model. The firm noted that the company plans to begin commercial production of permanent magnets used in critical military platforms and in green energy applications such as electric vehicles (EVs), wind turbines, and humanoids/robotics by the end of 2025. That said, the firm remains wary of execution risk.&nbsp;MP Materials recently announced a joint venture with Saudi mining company Maaden in November that could significantly boost its ability to expand its magnetics business. The JV aims at developing a rare earth refinery in Saudi Arabia.Peer, NioCorp, focuses on developing several critical minerals from the proposed Elk Creek, Nebraska, Project, with a particular focus on three commercial mineral products — Niobium, Scandium, and Titanium — from a single ore body.Recently, H.C. Wainwright raised the price target for NioCorp to $9.40 from $8.25 and maintained a ‘Buy’ rating, citing the growing popularity of rare earths, the company’s current liquidity position, and its timeline with the U.S. Export-Import Bank,&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://in.investing.com/news/analyst-ratings/niocorp-stock-price-target-raised-to-950-from-825-at-hc-wainwright-93CH-5142253">according</a> to Investing.com.&nbsp;<a href="https://stocktwits.com/symbol/TMQ">Trilogy Metals (TMQ)</a>&nbsp; is an exploration and development company operating in the Ambler mining district located in northwestern Alaska, with a focus on critical metals such as high-grade copper, cobalt, zinc, lead, gold, and silver. Much of the company's gains came in early October, when Trump announced that the government would take a 10% stake in the company by investing $35.6 million to support mining exploration in Alaska’s Ambler Mining District.<h2 class="st-heading-2">Retail Mood Muted</h2>On Stocktwits, retail sentiment toward&nbsp;TMC was ‘neutral,’ while retailers held a ‘bearish’ view of the other three. While a bullish watcher&nbsp;<a href="https://stocktwits.com/Wolf0vs/message/639665730">said</a> he has never sold a TMC stock since 2023, a few held an outright negative opinion of the stock.<h2 class="st-heading-2">Valuations After Run-up</h2>In terms of trailing price-to-book ratio, MP Material’s valuation is 4.7 times compared to 5.9 times for Triliogy Metals and 4.3 times for NioCorp. TMC trades at a hefty 35.35 ratio.According to Koyfin, the average analyst price target suggests upside potential of 27% for TMC Metal, 52% for MP Materials, 35% for Trilogy Metals and 142% for NioCorp.Considering the current valuation and upside potential, NioCorp appears to be a better bet, followed by MP Materials.The industry is set to make waves yet again in 2026. Morgan Stanley named REEs and critical minerals as one of the key themes for 2026.<blockquote>“Consensus view is that the U.S. govt will continue to provide financial support for REE/CM reshoring efforts.”</blockquote>The firm also flagged other efforts the Trump administration has taken to prop up the critical mineral industry, apart from taking direct equity stakes in some companies. These include implementing a 10-year price floor for MP Materials Neodymium &amp; Praseodymium, REEs crucial for magnets, and materials-specific tariffs.Going forward, Morgan Stanley expects the government support to come in the form of “a more targeted, fiscally contained government framework in which support is delivered through project-level grants/loans and potentially complemented by a Section 232-equivalent mechanism for rare earths and critical minerals.”For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/soft-inflation-ushers-santa-onto-wall-street-will-seasonal-trends-follow/cLeiYWMRErM">Soft Inflation Ushers Santa Onto Wall Street — Will Seasonal Trends Follow?</a>

Samples of rare-earth minerals from Baiyun'ebo or Bayan Obo mining district are on display at the Institute of Geology and Geophysics, Chinese Academy of Sciences (IGGCAS) on May 17, 2025, in Beijing, China. 

TMC Vs TMQ Vs NioCorp Vs MP Materials: These 4 Critical Metal Stocks Delivered Standout Gains In 2025 — Which Has the Best Risk-Reward Now?

Geopolitical tensions lifted critical metal stocks as U.S. reshoring efforts, government backing, and supply fears drove gains.

Equity

Geopolitical tensions lifted critical metal stocks as U.S. reshoring efforts, government backing, and supply fears drove gains.


Mirador Capital Partners LP Acquires 339,174 Shares of TMC the metals company Inc. $TMC

Mirador Capital Partners LP grew its holdings in TMC the metals company Inc. (NASDAQ:TMC - Free Report) by 306.1% in the 3rd quarter, according to its most recent disclosure with the Securities...

TMC the metals company Inc. (NASDAQ:TMC) Receives Consensus Recommendation of "Hold" from Analysts

TMC the metals company Inc. (NASDAQ:TMC - Get Free Report) has been given an average rating of "Hold" by the five analysts that are covering the firm, MarketBeat Ratings reports. One analyst has...

TMC the metals (NASDAQ:TMC) Stock Price Up 7.2% - What's Next?

TMC the metals (NASDAQ:TMC) Trading Up 7.2% - What's Next...

TMC the metals (NASDAQ:TMC) Shares Down 6.1% - Here's What Happened

TMC the metals (NASDAQ:TMC) Stock Price Down 6.1% - Time to Sell...

210,487 Shares in TMC the metals company Inc. $TMC Bought by Legal & General Group Plc

Legal & General Group Plc acquired a new stake in TMC the metals company Inc. (NASDAQ:TMC - Free Report) during the 2nd quarter, according to its most recent disclosure with the SEC. The fund...

<ul class="summary-bullets"><li>The deal lifts CRML’s total committed offtake to 75% of Tanbreez’s rare earth concentrate, adding to earlier agreements with UCORE and ReAlloys.</li><li>The Romanian joint venture will receive half of the mine’s output for its entire lifespan.</li><li>Tanbreez is one of the world’s largest known rare-earth deposits, projected to contain over 27% of heavy rare-earth elements.</li></ul>Critical Metals Corp. (CRML) shares rose more than 5% in premarket trading on Tuesday, after the miner announced a joint venture with Romania’s state-owned Fabrica De Prelucreare A Concentratelor De Uraniu S.R.L. (FPCU) aimed at building a fully integrated rare earth supply chain.<a href="https://stocktwits.com/symbol/CRML">CRML</a> was among the top trending tickers on Stocktwits.<h2 class="st-heading-2">Details of The Agreement</h2>The term sheet gives CRML long-term rights to 50% of all Tanbreez rare earth concentrate and lays out plans to build, fund, and launch a modern rare earth processing facility in Romania. The planned Romanian facility will process this feedstock into rare earth metals and advanced materials, including aerospace- and military-grade magnets.Tanbreez is one of the world’s largest known rare-earth deposits, projected to contain over 27% of heavy rare-earth elements. The site also offers a key supply chain advantage with direct shipping access to the North Atlantic Ocean.The deal lifts CRML’s total committed offtake to 75% of Tanbreez’s rare earth concentrate, adding to earlier agreements with UCORE and ReAlloys. The Romanian joint venture will receive half of the mine’s output for its entire lifespan, helping supply European industries and defense sectors.CRML and FPCU will finalize the technical and commercial framework for the&nbsp;joint venture, including plant design and commercialization plans. The American miner said that updated feasibility models and timelines are expected by&nbsp;the first quarter (Q1) of 2026.Both CRML and the Romanian government will also apply for the recently announced €3.5 billion ($4.07 billion) package for the supply of rare earth metals to the EU.“This is a monumental game-changer for CRML and the entire Western world. By capturing immense downstream value from Tanbreez concentrate, we're not just building a plant — we're dismantling China's stranglehold on rare earths and empowering Europe with independent, secure supplies for its defense and national security needs,” said Tony Sage, CEO and Chairman of CRML.<h2 class="st-heading-2">U.S. Rare Earth Push</h2>The rare earth minerals sector has drawn significant attention this year, playing a key role in the U.S.-China trade tensions. With China dominating roughly 70% of global mining and nearly 90% of processing, the U.S. government has ramped up efforts to increase domestic production, investing in companies like Lithium Americas&nbsp;(LAC), MP Materials&nbsp;(MP), Critical Metals, and Trilogy Metals (TMQ).Last month, MP Materials signed a three-way joint venture with Saudi Arabia’s state-owned miner Maaden and the U.S. Department of War (DoW) to build a major rare-earth refinery in the country.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Retail sentiment on Stocktwits remained in the ‘extremely bullish’ zone over the past 24 hours, accompanied by ‘high’ message volumes.<figure class="image"><img style="aspect-ratio:931/100;" src="https://news.stocktwits-cdn.com/CRML_png_0492e39097.webp" alt="CRML.png" width="931" height="100"><figcaption>CRML's Sentiment Meter and Message Volumes in Premarket Trading on Dec. 9 | Source: Stocktwits</figcaption></figure>However, one user expects CRML stock to record strong gains.<stembedurl>https://stocktwits.com/tt01/message/638581486</stembedurl>Year-to-date, the stock has gained nearly 45%.€1 = $1.16Read Also: <a href="https://stocktwits.com/news-articles/markets/equity/here-s-how-gold-is-performing-ahead-of-fed-rate-decision-tomorrow/cLIruj6REZ9">Here’s How Gold Is Performing Ahead Of Fed Rate Decision Tomorrow</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Drag-line excavator mines rare earth materials. (Photo by Kostiantyn Liberov/Libkos/Getty Images)

CRML Stock Soars After Romania JV Agreement To Challenge China’s Rare Earth Dominance

The deal gives Critical Metals the long-term rights to 50% of all Tanbreez rare earth concentrate.

TMC the metals company Inc. $TMC Shares Sold by Baird Financial Group Inc.

Baird Financial Group Inc. decreased its position in TMC the metals company Inc. (NASDAQ:TMC - Free Report) by 19.8% in the second quarter, according to its most recent 13F filing with the Securities...

TMC the metals co., Inc. is a deep-sea minerals exploration company focused on the collection and processing of polymetallic nodules found on the seafloor in international waters of the Clarion Clipperton Zone in the Pacific Ocean (CCZ). These nodules contain high grades of four metals (nickel, copper, cobalt, manganese) which can be used as (i) feedstock for battery cathode precursors (nickel, cobalt and manganese sulfates, or intermediate nickel-copper-cobalt matte) for electric vehicles (EV) and renewable energy storage markets, (ii) copper cathode for EV wiring, energy transmission and other applications and (iii) manganese silicate for manganese alloy production required for steel production. The company was founded in 2021 and is headquartered in Vancouver, Canada.

TMC
TMC the metals company Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest TMC News

TMCTMC the metals company Inc